
Mitchell Steiner
Advertisement
Articles by Mitchell Steiner


Advertisement
Latest Updated Articles
7 TiP Randomized, Multicenter, International Phase 3 ARTEST Study to Evaluate the Efficacy and Safety of Enobosarm Versus Active Control for the Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Previously Received an Estrogen-Blocking Agent and CDK4/6 InhibitorPublished: April 18th 2022 | Updated:
8 TiP Randomized, Multicenter, Phase 3 Study to Evaluate the Combination of Enobosarm and Abemaciclib Compared With Estrogen-Blocking Agent for the Second-Line Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Have Previously Received Palbociclib and an Estrogen-Blocking Agent Combination TherapyPublished: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
TLD-1433 Exhibits Early Efficacy in BCG-Unresponsive NMIBC CIS
2
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
3
FDA Grants Fast Track Designation to Pelareorep in KRAS+ MSS Metastatic CRC
4
Maximizing Control Via Radiation in High-Risk and Recurrent Breast Cancer
5

